Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The fund seeks real return consistent with reasonable investment risk.The Adviser defines real return as total return reduced by the expected impact of inflation. In seeking real return,the Adviser expects to allocate the fund's assets among four general investment categories: inflation-protected debt securities,floating rate loans,commodity-linked derivative instruments and related investments,and REITs and other real estate related investments.The fund's neutral mix,or the benchmark for its combination of investments in each category over time,is approximately 30% inflation-protected debt securities,25% floating rate loans,25% commodity-linked derivative instruments and related investments,and 20% REITs and other real estate related investments.The Adviser regularly reviews the fund's allocation and makes changes gradually over time to favor investments that it believes provide the most favorable outlook for achieving the fund's objective.By allocating investments across different types of securities,the Adviser attempts to moderate the significantrisks of each category through diversification. For purposes of these allocations, the Adviser will include the fund's investmentsin master limited partnerships (MLPs) in the commodity-linked derivative instruments and related investments category.The floating rate loan category includes floating rate loans,many of which are lower-quality debt securities (those of less than investment-grade quality, also referred to as high yield debt securities or junk bonds), and other floating rate securities such asmoney market securities, repurchase agreements, and shares of money market and short-term bond funds.The inflation-protected debt category is a passively managed investment strategy attempting to track the Bloomberg Barclays U.S. Treasury Inflation-Protected Securities (TIPS) Index (Series-L). The index is composed of inflation-protected debt securities issued by the U.S.Treasury. The Adviser may use statistical sampling techniques to attempt to replicate the returns of the index using a smaller number of securities.Statistical sampling techniques attempt to match the investment characteristics of the index and the fund bytaking into account such factors as duration, maturity, interest rate sensitivity, security structure,and credit quality.Thecommodity-linked derivative instruments and related investments category includes commodity-linked notes,other commodity-linked derivative instruments,such as commodity futures and swaps,and commodity-related equity securities that seek to outperform the performance of an index chosen by the Adviser to represent the commodities market,as well as short-term investment-grade debt securities.As of September 30, 2019,the Adviser was using the Bloomberg Commodity Index Total Return to represent the commodities market.

Net Asset Value

as of 5:22 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.21%
  • 1 Month
  • +0.75%
  • 3 Months
  • +2.39%
  • 1 Yr Return
  • +15.16%
  • 5 Yr Return
  • +8.15%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Other 56.65%
Bonds 28.87%
Stocks 9.50%
Preferred 3.74%
Cash 0.95%
Convertible 0.29%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 7.24 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 4.11 3.49 1.05
Beta 0.40 0.40 0.55
R Squared 0.02 0.03 0.06
Std Deviation 9.64 7.61 6.86
Sharpe Ratio 0.61 0.57 n/a

Purchase Information

as of 5:17 PM ET 09/16/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +17.69%
  • +22.22%
+17.69% +22.22%
3 Year
  • +6.55%
  • +5.84%
+6.55% +5.84%
10 Year
  • +2.87%
  • +2.69%
+2.87% +2.69%
Life Of Fund
  • +3.25%
  • +3.16%
+3.25% +3.16%

Top 10 Holdings

Symbol Company Name % Of Assets
n/a

Recent Articles from TheStreet

Elon Musk Starlink Lead

SpaceX CEO Elon Musk Says Starlink Exits Beta Next Month

SpaceX CEO Elon Musk says the company’s Starlink high-speed internet service will come out of beta testing next month.

Wall Street Lead

Cramer: Using Short-Term Moves to Tweak Your Portfolio

Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.

10. Chemical & petrochemical pharma sh

Jensen: These Three Healthcare Stocks Are Worth a Look

Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.

18. Apple Inc. (AAPL)

Parus Files Second Patent Infringement Lawsuit Against Apple

Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.

12. Software engineer

Business Software Provider AvidXchange Files for IPO

Accounts payable software provider AvidXchange on Friday filed for a initial public offering.

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.